Tvardi Therapeutics (TVRD) shares rose more than 52% in Wednesday trading after Raymond James upgraded the stock to outperform from market perform.
Trading volume stood at more than 31.6 million shares, compared with a daily average of 1.3 million.
Price: $4.69, Change: $+1.59, Percent Change: +51.29%